Skip to main content

Haolin Xu

Biostatistician, Senior
Duke Clinical Research Institute
Duke Box 3850, 200 Morris St 4412, Durham, NC 27701
200 Morris St, 4412, Durham, NC 27701

Current Duke Appointments & Affiliations


Recent Scholarly Works


Lost to Follow-Up in Pragmatic Trials With Remote Follow-Up: Insights From CONNECT-HF and TRANSFORM-HF.

Journal article J Am Heart Assoc · July 25, 2026 BACKGROUND: Pragmatic trials commonly use remote follow-up to reduce participant burden and costs. However, these approaches may increase the risk of lost to follow-up (LTFU). We identified patient- and site-level factors associated with LTFU in 2 large, p ... Full text Link to item Cite

One-Year Outcomes in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction Prescribed Quadruple Medical Therapy at Discharge.

Journal article JAMA Cardiol · March 1, 2026 IMPORTANCE: Among patients with heart failure with reduced ejection fraction (HFrEF) in US clinical practice, the residual risk of poor clinical outcomes despite quadruple medical therapy is not well characterized. OBJECTIVE: To evaluate clinical outcomes ... Full text Link to item Cite
View All Scholarly Works

Recent Grants


Balancing Risks and Benefits of Direct Oral Anticoagulants in Older Ischemic Stroke Patients with Atrial Fibrillation

ResearchBiostatistician · Awarded by University of Texas Southwestern Medical Center · 2022 - 2026

The Impact of Quality Metrics on Outcomes among Elderly Heart Failure Patients

ResearchStatistician · Awarded by Dartmouth College · 2019 - 2021

Balancing Risks and Benefits of Direct Oral Anticoagulants in Older Ischemic Stroke Patients with Atrial Fibrillation

ResearchStatistician · Awarded by National Institutes of Health · 2020 - 2021

View All Grants